Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment
The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nagase, H., & Woessner, J. F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.21491 · Cited by 3,912
Matrix Metalloproteinases: A Review
Birkedal-Hansen, H., Moore, W. G. I., Bodden, M. K., Windsor, L. J., Birkedal-Hansen, B., DeCarlo, A., & Engler, J. A. (1993) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411930040020401 · Cited by 2,970
A matrix metalloproteinase expressed on the surface of invasive tumour cells
Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E., & Seiki, M. (1994) · Nature · doi:10.1038/370061a0 · Cited by 2,551
Self-citationMolecular Bases of the Acute Coronary Syndromes
Libby, P. (1995) · Circulation · doi:10.1161/01.cir.91.11.2844 · Cited by 2,028
Yu, Q., & Stamenkovic, I. (2000) · Genes & Development · doi:10.1101/gad.14.2.163 · Cited by 1,754
Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase
Strongin, A. Y., Collier, I., Bannikov, G., Marmer, B. L., Grant, G. A., & Goldberg, G. I. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.10.5331 · Cited by 1,593
Changing views of the role of matrix metalloproteinases in metastasis
Chambers, A. F., & Matrisian, L. M. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.17.1260 · Cited by 1,588
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
Nelson, A. R., Fingleton, B., Rothenberg, M. L., & Matrisian, L. M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.5.1135 · Cited by 1,554
Brooks, P. C., Strömblad, S., Sanders, L. C., von Schalscha, T. L., Aimes, R. T., Stetler-Stevenson, W. G., Quigley, J. P., & Cheresh, D. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81235-0 · Cited by 1,552
Holmbeck, K., Bianco, P., Caterina, J., Yamada, S., Kromer, M., Kuznetsov, S. A., Mankani, M., Gehron Robey, P., Poole, A. R., Pidoux, I., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80064-1 · Cited by 1,298
Cited by
Visse, R., & Nagase, H. (2003) · Circulation Research · doi:10.1161/01.res.0000070112.80711.3d · Cited by 4,575
Targeting RAS signalling pathways in cancer therapy
Downward, J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc969 · Cited by 3,256
Tumour-cell invasion and migration: diversity and escape mechanisms
Friedl, P., & Wolf, K. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1075 · Cited by 3,222
Bissell, M. J., & Radisky, D. (2001) · Nature Reviews Cancer · doi:10.1038/35094059 · Cited by 2,180
Compensation mechanism in tumor cell migration
Wolf, K., Mazo, I., Leung, H., Engelke, K., von Andrian, U. H., Deryugina, E. I., Strongin, A. Y., Bröcker, E.-B., & Friedl, P. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200209006 · Cited by 1,391
Strategies for MMP inhibition in cancer: innovations for the post-trial era
Overall, C. M., & López-Otín, C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc884 · Cited by 1,349
“So, despite the large number of unsuccessful trials, which often have reasonable explanations for failur”
BackgroundMatrix Metalloproteinases: Role In Arthritis
Burrage, P. (2006) · Frontiers in Bioscience · doi:10.2741/1817 · Cited by 1,292
Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy
Overall, C. M., & Kleifeld, O. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1821 · Cited by 1,214
IL-1 is required for tumor invasiveness and angiogenesis
Voronov, E., Shouval, D. S., Krelin, Y., Cagnano, E., Benharroch, D., Iwakura, Y., Dinarello, C. A., & Apte, R. N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0437939100 · Cited by 1,023
Extracellular Vesicles in Cancer: Exosomes, Microvesicles and the Emerging Role of Large Oncosomes
Minciacchi, V. R., Freeman, M. R., & Di Vizio, D. (2015) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.02.010 · Cited by 963
Role of the Matrix Metalloproteinase and Plasminogen Activator–Plasmin Systems in Angiogenesis
Pepper, M. S. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0701.093685 · Cited by 777
Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease
Raffetto, J. D., & Khalil, R. A. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.004 · Cited by 752
Tumor biomarkers for diagnosis, prognosis and targeted therapy
Zhou, Y., Tao, L., Qiu, J., Xu, J., Yang, X., Zhang, Y., Tian, X., Guan, X., Cen, X., & Zhao, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01823-2 · Cited by 720
Gelatinase-mediated migration and invasion of cancer cells
Björklund, M., & Koivunen, E. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.03.001 · Cited by 661
Matrix metalloproteinases in cancer: Prognostic markers and therapeutic targets
Vihinen, P., & Kähäri, V. (2002) · International Journal of Cancer · doi:10.1002/ijc.10329 · Cited by 637
Hu, Y., Li, C.-Y., Wang, X.-M., Yang, Y.-H., & Zhu, H.-L. (2014) · Chemical Reviews · doi:10.1021/cr400131u · Cited by 607
Axis of evil: molecular mechanisms of cancer metastasis
Bogenrieder, T., & Herlyn, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206757 · Cited by 593
Lambert, E., Dassé, E., Haye, B., & Petitfrère, E. (2004) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2003.09.008 · Cited by 541
de Almeida, L. G. N., Thode, H., Eslambolchi, Y., Chopra, S., Young, D., Gill, S., Devel, L., & Dufour, A. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000349 · Cited by 535
The role of gelatinases in colorectal cancer progression and metastasis
Mook, O. R. F., Frederiks, W. M., & Van Noorden, C. J. F. (2004) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2004.09.006 · Cited by 511
Role of matrix metalloproteinases (MMPs) in colorectal cancer
Zucker, S., & Vacirca, J. (2004) · Cancer and Metastasis Reviews · doi:10.1023/a:1025867130437 · Cited by 506
Self-citationTargeting matrix metalloproteinases in cancer: Bringing new life to old ideas
Cathcart, J., Pulkoski-Gross, A., & Cao, J. (2015) · Genes & Diseases · doi:10.1016/j.gendis.2014.12.002 · Cited by 504
Self-citationMembrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion
Seiki, M. (2003) · Cancer Letters · doi:10.1016/s0304-3835(02)00699-7 · Cited by 406
Membrane-type matrix metalloproteinases: Their functions and regulations
Itoh, Y. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.03.004 · Cited by 401
Cell Migration and Invasion Assays as Tools for Drug Discovery
Hulkower, K. I., & Herber, R. L. (2011) · Pharmaceutics · doi:10.3390/pharmaceutics3010107 · Cited by 395
Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer
Kerkelä, E., & Saarialho‐Kere, U. (2003) · Experimental Dermatology · doi:10.1034/j.1600-0625.2003.120201.x · Cited by 345
Towards third generation matrix metalloproteinase inhibitors for cancer therapy
Overall, C. M., & Kleifeld, O. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603043 · Cited by 340
Takenaka, Y., Fukumori, T., & Raz, A. (2002) · Glycoconjugate Journal · doi:10.1023/b:glyc.0000014084.01324.15 · Cited by 321
Missing the target: matrix metalloproteinase antitargets in inflammation and cancer
Dufour, A., & Overall, C. M. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.02.004 · Cited by 312
Matrix metalloproteinases in cancer
Itoh, Y., & Nagase, H. (2002) · Essays in Biochemistry · doi:10.1042/bse0380021 · Cited by 309
Cancer invasion and metastasis: changing views
Duffy, M., McGowan, P., & Gallagher, W. (2008) · The Journal of Pathology · doi:10.1002/path.2282 · Cited by 302
MATRIX METALLOPROTEINASE-2 (MMP-2) AND MMP-9 IN PULMONARY PATHOLOGY
Chakrabarti, S., & Patel, K. D. (2005) · Experimental Lung Research · doi:10.1080/019021490944232 · Cited by 279
The vermiform appendix impacts the risk of developing Parkinson’s disease
Killinger, B. A., Madaj, Z., Sikora, J. W., Rey, N., Haas, A. J., Vepa, Y., Lindqvist, D., Chen, H., Thomas, P. M., Brundin, P., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aar5280 · Cited by 279
Requirement for Arf6 in breast cancer invasive activities
Hashimoto, S., Onodera, Y., Hashimoto, A., Tanaka, M., Hamaguchi, M., Yamada, A., & Sabe, H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401753101 · Cited by 270
Jiang, H., & Li, H. (2021) · BMC Cancer · doi:10.1186/s12885-021-07860-2 · Cited by 261
Role of ADAMs in Cancer Formation and Progression
Duffy, M. J., McKiernan, E., O'Donovan, N., & McGowan, P. M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1585 · Cited by 259
The ADAMs family of proteases: new biomarkers and therapeutic targets for cancer?
Duffy, M. J., Mullooly, M., O'Donovan, N., Sukor, S., Crown, J., Pierce, A., & McGowan, P. M. (2011) · Clinical Proteomics · doi:10.1186/1559-0275-8-9 · Cited by 210
“As mentioned above, a particularly encouraging finding with INCB3619 and INCB7839 is that they do not appear to cause musculoskeletal side effects [33], which was a major problem with the early metalloproteinase inhibitors investigated [76,77].”
ResultCathepsin L, target in cancer treatment?
Lankelma, J. M., Voorend, D. M., Barwari, T., Koetsveld, J., Van der Spek, A. H., De Porto, A. P. N. A., Van Rooijen, G., & Van Noorden, C. J. F. (2010) · Life Sciences · doi:10.1016/j.lfs.2009.11.016 · Cited by 180
Intricate Functions of Matrix Metalloproteinases in Physiological and Pathological Conditions
Mittal, R., Patel, A. P., Debs, L. H., Nguyen, D., Patel, K., Grati, M., Mittal, J., Yan, D., Chapagain, P., & Liu, X. Z. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25430 · Cited by 179
Baillat, D., Bègue, A., Stéhelin, D., & Aumercier, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200088200 · Cited by 84
Ademosun, A. O., Oboh, G., Olasehinde, T. A., & Adeoyo, O. O. (2018) · Oriental Pharmacy and Experimental Medicine · doi:10.1007/s13596-017-0292-8 · Cited by 42
“MMPs are produced by cancer cells to invade surrounding tissues (Zucker et al. 2000).”
BackgroundKilian, M., Gregor, J. I., Heukamp, I., Hanel, M., Ahlgrimm, M., Schimke, I., Kristiansen, G., Ommer, A., Walz, M. K., Jacobi, C. A., et al. (2006) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2006.08.004 · Cited by 32
Metadata
- Authors
- Zucker, S., Cao, J., & Chen, W.-T.
- Venue
- Oncogene
- Published
- 2000-12-27
- Volume
- 19
- Issue
- 56
- Pages
- 6642-6650
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2102884576
- Cited by
- 550
- References
- 61
- FWCI
- 12.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.